Walgreens Boots Alliance Inc (WBA) Director Nancy M. Schlichting Sells 7,050 Shares

Walgreens Boots Alliance Inc (NASDAQ:WBA) Director Nancy M. Schlichting sold 7,050 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total value of $555,610.50. Following the completion of the transaction, the director now owns 5,709 shares of the company’s stock, valued at approximately $449,926.29. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

NASDAQ WBA opened at $80.81 on Friday. The firm has a market capitalization of $75.71 billion, a PE ratio of 13.42, a PEG ratio of 1.27 and a beta of 0.74. Walgreens Boots Alliance Inc has a 52 week low of $59.07 and a 52 week high of $83.18. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The company had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. As a group, equities research analysts expect that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be paid a $0.44 dividend. The ex-dividend date is Thursday, November 8th. This represents a $1.76 annualized dividend and a dividend yield of 2.18%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlueMountain Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $103,000. CSat Investment Advisory L.P. acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $104,000. Squar Milner Financial Services LLC acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $106,000. Asset Dedication LLC grew its stake in shares of Walgreens Boots Alliance by 204.6% during the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock worth $115,000 after purchasing an additional 1,060 shares during the period. Finally, Kaizen Advisory LLC grew its stake in shares of Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after purchasing an additional 1,083 shares during the period. 64.29% of the stock is owned by institutional investors.

Several equities analysts have issued reports on the company. Barclays lifted their price objective on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research report on Friday, October 12th. BidaskClub upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, September 12th. Citigroup lifted their price objective on Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research report on Friday, October 12th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Tuesday, September 25th. Finally, Robert W. Baird lifted their price objective on Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a “neutral” rating in a research report on Tuesday, September 11th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $78.22.

TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance Inc (WBA) Director Nancy M. Schlichting Sells 7,050 Shares” was first published by WKRB News and is owned by of WKRB News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.wkrb13.com/2018/11/25/walgreens-boots-alliance-inc-wba-director-nancy-m-schlichting-sells-7050-shares.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: What is the Coverage Ratio?

Insider Buying and Selling by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply